Where is molecular imaging headed? Experts weigh in

10/14/2013 | AuntMinnie.com (free registration)

Molecular imaging's full potential in health care will not be realized until education of clinicians catches up with advances in the field, according to Robert Gillies of the Moffitt Cancer Center in Tampa, Fla. "There really aren't enough senior-level people to do a full-out establishment of a new track in radiology, but we see this as inevitable," he said, noting that some institutions are ahead of the curve. Meanwhile, Dr. Anthony Shields of Wayne State University argues that molecular imaging is radically changing drug development, but James Basilion of Case Western Reserve University says meeting the bar for FDA approval and then CMS payment is challenging. "Trying to prove that an agent will change treatment ... is extremely difficult," Basilion said, citing the example of amyloid imaging.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX